PepTalk 2017
PepTalk 2017

Pipeline Four Header

Cambridge Healthtech Institute’s Fourth Annual
Optimizing Expression Platforms
Transient, Stable or Both?
January 12-13, 2017 | Hilton San Diego Bayfront | San Diego, CA

Speed, limiting risk and protein quality are often cited as advantages of transient protein production (TPP), while stable transfection – the longer and more complex process – has the advantage of producing long-term expression of the biotherapeutic of interest. The rapidly increasing need for recombinant proteins necessitates further improvements in both technologies.

Cambridge Healthtech Institute’s Fourth Annual Optimizing Expression Platforms conference convenes protein expression specialists who share their experiences of the differences, tradeoffs, and improvements in producing recombinant proteins in transient or stable production systems, and who investigate their advantages and disadvantages and when to use both.

We invite presentation proposals on the following preliminary topics:

  • CHO cell lines
  • HEK293 cell lines
  • Plants
  • Expression vector selection
  • Transfection optimization
  • Transfection performance
  • Automation in transient transfection
  • Cell culture optimization
  • Cell culture monitoring
  • Automation of cell maintenance
  • Optimizing the secretion of recombinant proteins
  • Improvements of cytoplasmic expression
  • Solubility and protein folding
  • Glycosylation and other posttranslational modifications
  • Increasing speed and lowering cost
  • Stable expression vs. transient expression
  • Establishing an efficient production facility

Please click here to submit a speaking proposal for review.

Deadline for submission: May 27, 2016

All proposals are subject to review by the Scientific Advisory Committee to ensure the overall quality of the conference program. Please note that due to limited speaking slots, preference will be given to abstracts from those within pharmaceutical and biopharmaceutical companies, regulators and those from academic centers. Additionally, as per CHI policy, a select number of vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For questions about the meeting, please contact:

Mary Ann Brown
Executive Director, Conferences
Cambridge Healthtech Institute
Phone: 781-972-5497

For partnering & sponsorship information, please contact:

Companies A-K
Jason Gerardi
Manager, Business Development
Cambridge Healthtech Institute
Phone: 781-972-5452
Fax: 781-972-5470

Companies L-Z
Carol Dinerstein
Director, Business Development
Cambridge Healthtech Institute
Phone: 781-972-5471
Fax: 781-972-5470